Me-RIP experimental results explained that the increase of m6A modification of TK1 in ESCC tissues may account for such expressional upregulation (26), and the PAR-CLIP test revealed that IGF2BP2 recognized m6A modification of TK1 mRNA to maintain its stability. Here, IGF2BP2 is linked to esophageal squamous cell carcinoma.